
Intra-Cellular Therapies Inc
NASDAQ:ITCI

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ITCI's stock price target?
Not Available
ITCI doesn't have any price targets made by Wall Street professionals.
What is Intra-Cellular Therapies Inc's Revenue forecast?
Projected CAGR
48%
For the last 8 years the
compound annual growth rate for
Intra-Cellular Therapies Inc's revenue is
163%.
The projected
CAGR
for the next 3 years is
48%.